Safety of an IV Formulation of Carbamazepine

Epilepsy Research - Netherlands
doi 10.1016/j.eplepsyres.2009.01.013
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Elsevier BV

Related search

Formulation and Evaluation of Chitosan Solid Lipid Nanoparticles of Carbamazepine

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2012English

Formulation and Evaluation of Carbamazepine Tablets Using Biosurfactant in Ternary Solid Dispersion System

Indian Journal of Pharmaceutical Education and Research
ToxicologyPharmaceuticsPharmacology
2020English

An Interesting Case of Carbamazepine-Induced Stevens–Johnson Syndrome

Drug Safety - Case Reports
Pharmacology
2018English

Evaluation of Safety and Immunotoxicity of Immunol, a Polyherbal Formulation in Rats

Journal of Pharmacology and Toxicology
ToxicologyPharmaceuticsPharmacology
2010English

Carbamazepine-Induced Hypogammaglobulinemia

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2012English

Carbamazepine Furfural Hemisolvate

Acta Crystallographica Section E Structure Reports Online
2005English

Appendix A: An Example of Formulation of an Analysis

English

Mechanisms of Carbamazepine-Induced Antidiuresis.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1993English

Safety, Tolerability, and Pharmacokinetics of 6-Month Daily Dosing of an Oral Formulation of Cyclosporine (ATOPICA for Cats®) in Cats

Journal of Veterinary Pharmacology and Therapeutics
VeterinaryPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy